Alector shares rose 21.5% to $2.19 after Roche signed a license agreement worth up to $1.27 billion for the company's Parkinson's disease treatments.

Zhitongcaijing · 2d ago
Alector shares rose 21.5% to $2.19 after Roche signed a license agreement worth up to $1.27 billion for the company's Parkinson's disease treatments.